Gentex Warns China Sales Will Keep Falling Through 2027
Gentex (NASDAQ: GNTX) stock drops on mixed Q2 results: EPS beats estimates, revenue misses. Company reaffirms FY26 and FY27 guidance.
Read original at benzingaStocks · News reference
JP Morgan Maintains Neutral on Gentex, Lowers Price Target to $27
JP Morgan analyst Rajat Gupta maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $28 to $27.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 10, 2026, 6:51 PM
- Checked
- Aug 10, 2026, 6:51 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Gentex shares are trading lower after the company reported mixed Q2 financial results.
Read original at benzingaGentex Affirms FY2027 Sales Guidance of $2.800B-$2.900B vs $2.826B Est
Gentex (NASDAQ:GNTX) affirms FY2027 sales outlook from $2.800 billion-$2.900 billion to $2.800 billion-$2.900 billion vs $2.826 billion estimate.
Read original at benzinga